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Assembly, maturation, and degradation of the
supraspinatus enthesis
Peter T. Jensen, BSca, Kate L. Lambertsen, PhDa,b, Lars H. Frich, MD, PhDa,c,*
aDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark
bDepartment of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Odense,
Denmark
cDepartment of Orthopaedics and Traumatology, Odense University Hospital, Odense, Denmark
The development of the rotator cuff enthesis is still poorly understood. The processes in the early and late
developmental steps are gradually elucidated, but it is still unclear how cell activities are coordinated during
development and maturation of the structured enthesis. This review summarizes current knowledge
about development and age-related degradation of the supraspinatus enthesis. Healing and repair of an
injured and degenerated supraspinatus enthesis also remain a challenge, as the original graded transition-
al tissue of the fibrocartilaginous insertion is not re-created after the tendon is surgically reattached to bone.
Instead, mechanically inferior and disorganized tissue forms at the healing site because of scar tissue for-
mation. Consequently, the enthesis never reaches mechanical properties comparable to those of the native
enthesis. So far, no novel biologic healing approach has been successful in enhancing healing of the injured
enthesis. The results revealed in this review imply the need for further research to pave the way for better
treatment of patients with rotator cuff disorder.
Level of evidence: Narrative Review
© 2017 The Author(s). This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Rotator cuff (RC) lesions are one of the most common con-
ditions affecting the shoulder. The prevalence of RC tears is
age dependent, and the prevalence of both partial- and full-
thickness RC tears increases markedly after 50 years of age.51,83
The etiology of RC diseases is multifactorial, but the supra-
spinatus (SS) tendon is particularly vulnerable to become
injured.8
Longitudinal data suggest that tears progress over time.84
Approximately 30% of surgical repairs will fail, and the failure
rate is as high as 90% in patients with large chronic tears.21,74
The attachment site of the SS tendon at the footprint of
the greater tuberosity of the humerus defines a classic enthesis
made of 4 zones (Fig. 1). Degenerative changes may be seen
in all 4 zones, and the severity of a lesion depends on the
degenerative status of the enthesis and the adjacent tissues
involved. The SS tendon makes up the roof of the shoulder
joint, with the joint side of the tendon being covered by sy-
novial tissue and the acromial side by bursal tissue.8,46
It is believed that damage to the enthesis can induce an
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inflammatory reaction in the synovium or bursal tissue char-
acterized by expression of matrix-degrading molecules and
increased proliferation and differentiation of osteoclasts. This
may cause excessive degradation of the enthesis
matrix,20,44,46,68,76 leading to inadequate enthesis function. The
induced imbalance in the enthesis remodeling process is a
crucial event in the onset of RC tears and pathologic RC
disease.
Both the development and maturation of the native enthesis
are poorly understood. Muscle loading (ie, exertion of force
on tendon and bone by muscles) is critical for maturation of
the developing enthesis, as tissue deformity and diminished
mineralization are apparent in mouse models where 1 shoul-
der has been paralyzed.76,77 Besides muscle loading, molecular
factors are critical for the development of a functional
enthesis.61 Recently, several transcription factors, including
scleraxis (Scx), SRY-box 9 (Sox9), and GLI-Kruppel family
member 1 (Gli1), have been detected in early progenitor
cells of the developing enthesis and are crucial for
development.10,19,20,75 However, many questions remain un-
answered as to what drives development and differentiation
of the progenitor cells and how this is regulated.
The reparative capacity of the damaged enthesis is inad-
equate because the repaired enthesis never regenerates its native
structure after an SS tendon tear. Instead, excessive scar tissue
formation with inadequate biomechanical properties appears
at the repair site.70,71 Attempts to enhance the healing process
of damaged RC tendons have thus been directed toward bio-
logic enhancement at the repair site, just as stimulation of the
regenerative repair processes also has attracted attention.6,21
Transforming growth factor β (TGF-β) isoforms have re-
ceived special attention as important mediators in both scar-
less and scar-mediated healing processes.6,21
This review provides an overview of recent knowledge on
the developmental steps of the fibrocartilaginous enthesis, the
inflammatory response after SS tear, and the early charac-
teristics of enthesis healing after damage, touching on
therapeutic applications and considerations about biologic
augmentation.
Methods
A comprehensive search for peer-reviewed articles, excluding con-
ference papers or reports, was conducted on the basis of the following
MeSH terms: enthesis, rotator cuff, supraspinatus, growth and de-
velopment, inflammation, scleraxis, SRY-box 9, Indian hedgehog,
transforming growth factor β, arthritis, tendinopathy,
osteoclastogenesis, tumor necrosis factor, synovial, synovium, RANK,
and healing.
The following databases were searched for literature: PubMed,
Embase, and Web of Science. The reference section of each article
was also inspected to find additional articles. The process yielded
85 articles published from 1986 to September 2017.
Structure and function of the native enthesis
The native SS tendon enthesis develops postnatally and is viewed
as a 4-zone structure at maturity (Fig. 1). The tendinous first zone
Figure 1 The 4 zones of the fibrocartilaginous enthesis. The tendon zone consists of elongated tenocytes. At the border to the fibrocar-
tilaginous zone, the cells change from elongated fibroblasts to round chondrocytes, stacked in columns. The cells enlarge during the transition
from unmineralized to mineralized fibrocartilage. These hypertrophic cells are large cells imbedded in the mineralized matrix, gradually
mineralizing the matrix. The mineralized fibrocartilage firmly anchors into the underlying trabecular bone tissue. The tidemark separates
the 2 fibrocartilaginous zones.
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is composed primarily of type 1 collagen, with the proteoglycans
decorin and biglycan present. This zone is equivalent to the tendon
and is populated by tendon fibroblasts.23 The uncalcified fibrocar-
tilage of the second zone consists of collagen types 1 and 2 with
aggrecan, produced by resident fibrochondrocytes.19,34 Calcifica-
tion of the fibrocartilage occurs in the third zone of mineralized
fibrocartilage. This represents the actual transition of noncalcified
to calcified tissue, demarcated by a clear straight line called the tide-
mark (Fig. 1).6,7,19 It consists of hypertrophic fibrochondrocytes
producing collagen type 2, collagen type X, aggrecan, and alka-
line phosphatase (AP).19,34,69 Collagen type X is believed to stimulate
tissue mineralization.69 During maturity of the interface, the loss of
hypertrophic chondrocytes leads to increased mineralization density,
and although unexpected, collagen type X is still present.23 The fourth
zone consists of dense collagen type 1 bone23 (Fig. 1).
By histologic analysis of mouse SS tendons obtained from dif-
ferent embryonic (E) and postnatal (P) periods, Galatz et al identified
a transition zone between the SS tendon and the humeral head at
P7, with a visible 4-zone transition at P21 and P28 (Table I). The
fully mature interface was present at P56.23 In support of this,
Schwartz et al found a graded mineralization in the calcified zone
with the presence of hypertrophic chondrocytes in P7 mice.67 Using
micro–computed tomography scanning, they also observed a min-
eralization front adjacent to the SS tendon at P14 and an increase
in bone mineral density over time.67 A 4-zone transition with min-
eralized fibrocartilage was visible at P28.67 Interestingly, they also
noticed that the mineralization was located intercellularly but did
not always surround the cells. Thus, mineralization in some in-
stances occurred on only 1 side of the cells. This observation indicates
either that the cells are able to control mineralization or that min-
eralization occurs by transportation and deposition of calcium by
cells located away from the interface.67 The mineralized fibrocar-
tilage of the enthesis does not become reabsorbed, as observed for
bone formation. Instead, the mineralized fibrocartilage is main-
tained throughout life, and so it does not become vascularized.19
Developmental gene expression
Temporal expression of a number of genes has been linked to the
successful and functional development of the native enthesis. The
earliest progenitor cells found in the transitional zone express both
Scx and Sox9 (Scx+/Sox9+ cells).10,75 These cells also express growth
and differentiation factor 5 (GDF5), also known as bone morpho-
genetic protein 14 (BMP-14) or cartilage-derived morphogenetic
protein 1 (CDMP-1), during the early stage of development.20
Both Scx and Sox9 are crucial for the formation of a proper func-
tional enthesis.40 Scx is required for the development of tenocytes
in force-transmitting tendons and for matrix organization.54 Sox9
is required for chondrogenic condensation and thus the formation
of chondrocytes and primary cartilage, the template, in which the
long bones develop.3 Scx knockout mice display decreased bone
mineral density with age, decreased enthesis attachment strength,
more disordered orientation of collagen fibers, and loss of cellular
morphology gradient during development.40 This demonstrates the
detrimental effect of Scx loss and the necessity of this gene in proper
enthesis formation. Also, this suggests that Scx is required for for-
mation of bone eminences,10 which develop during the embryonic
Table I Time frame of the developing enthesis
Progress Time Species and model
Appearance of scx+/sox9+ progenitor cell line E11.5 Mouse, Sox9Cre/+; Ail4 and R26R67
Mouse, Scx-Sox9 KO10
Distinct SS tendon appears E13.5 Mouse, Scx−/−47
Mouse, CD-121
TGF-β3 expression in the developing enthesis E13.5-15.5 Mouse, CD-121
Shift from TGF-β3 to TGF-β1 expression E15.5 Mouse, CD-121
TGF-β1 expression in the developing enthesis E15.5-18.5 Mouse, CD-121
Cells in the SS tendon become increasingly more spindle shaped and oriented
with the tendon
E18.5 Mouse, CD-121
Two populations of Hh-responsive cells are evident P8 Mouse, ScxCre;Smofl/fl58
Initial mineralization
Fibrocartilage appears
Collagen type 1– and type 2–expressing fibrochondrocytes at the base of
the enthesis





Type X collagen expression occurs P14 Mouse, CD-121
Hh-responsive cells span the whole developing enthesis P15 Mouse, ScxCre;Smofl/fl58
Early maturity of enthesis with appearance of a modest 4-zone structure
Mineralized humeral head





Hh-responsive cells are restricted to the unmineralized area
Enthesis is fully mature with classical 4-zone structure




SS, supraspinatus; TGF, transforming growth factor; Hh, Hedgehog; E, embryonic; P, postnatally; KO, knockout.
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phase on the cartilaginous template of the bone and provide stable
footholds for the enthesis.10 The eminence develops from a pool of
Scx+/Sox9+ cells, directed from the progenitor cells that give rise
to the primary cartilage of developing bones by TGF-β.10 The initial
differentiation of these cells is regulated by expression of BMP-4
from cells at the insertional end of the developing tendon.11 BMP-4
induces differentiation of Scx+/Sox9+ cells into chondrocytes and
directs the formation of bone eminences, forming the initial attach-
ment between tendon and bone, the immature enthesis.10,11 TGF-β
signaling also induces Scx expression in tendon progenitor cells.61
Knockout of TGF-β2/3 or of the TGF-β2 receptor in tendon pro-
genitor cells results in a sudden decrease in Scx expression between
E11.5 and E12.5 and eventually a complete loss of expression in
the developing tendon.61 No change in proliferation or cell death
is found between E11.5 and E13.5, suggesting a role for TGF-β in
the differentiation and maintenance of tenocytes and in the speci-
fication of the eminence progenitor cells.61
Progenitor cells at the enthesis insertion site express Hedgehog
(Hh) proteins,19,45,66 proteins important in embryonic and postnatal
development.45 Binding of Hh to its receptor patched 1 (Ptch1)
prevents it from inhibiting the transmembrane protein smoothened
(Smo). Active Smo initiates a signaling cascade activating a tran-
scription factor of the family GLI-Kruppel, which then translocates
to the nucleus to initiate Hh gene transcription, such as Gli1 and
Ptch1.78 Without Hh ligand, Smo remains inactive through the
inhibitory effect of Ptch1, resulting in phosphorylation and proteo-
lytic cleavage of Gli, converting it to a transcriptional repressor.78
By a lineage-tracing experiment, labeling the Hh-specific gene
Gli1, researchers were able to locate and to follow Hh-responsive
cells during SS enthesis development.66 The results demonstrated
Hh-responsive cells as early as E16.5, which located between the
cartilage and tendon of the interface and proliferated and stacked
in columns between fiber bundles before mineralization, thereby
contributing to enthesis growth.19 The Hh-responsive cells first
spanned the entire fibrocartilage but were restricted to the
nonmineralized fibrocartilage at later stages of postnatal develop-
ment, as they differentiated from nonmineralizing fibrochondrocytes
into mineralizing, hypertrophic fibrochondrocytes.19 All the mature
fibrocartilaginous cells were found to be derived from these Hh-
responsive cells.66 As the progenitor cells differentiate, they change
collagen expression from only collagen type 1, to collagen types 1
and 2, to only collagen type 2, and finally to collagen type X.19
When the cells begin to mineralize the matrix, they express both
collagen type X and AP.19 The mineralization process starts from
the cells closest to the primary cartilage and proceeds toward the
tendon midsubstance, as the cells differentiate.19 Furthermore, the
Hh protein expressed in the developing fibrocartilaginous enthesis
has been shown to be Indian hedgehog (Ihh).45 Elimination of
Ihh-responsive cells, early in postnatal development, results in
reduced mineralization volume and reduced biomechanical
properties.66 Furthermore, inactivation of the Ihh signaling pathway,
Smo deletion, leads to reduced expression of extracellular matrix
component genes, such as collagen type 2, tenascin C, and lumican,
and mineralization genes, such as glypican 3 and asporin.45 Also,
activation of Ihh signaling in tenocytes caused abnormal collagen
type 2, tenascin C, and biglycan upregulation in the tendon
midsubstance. Studies also showed a lack of tidemark, with reduced
differentiation and a significant decrease in proteoglycan content,
mineralization, and biomechanical properties at later stages during
postnatal development.12,19,45,66 However, the collagen fiber organi-
zation was maintained overall parallel and organized for both the
nonmineralized and mineralized fibrocartilage, as in the tendon
midsubstance, but was irregularly shaped and coalesced at the
tidemark of the enthesis.12 Lack of mineralization and irregular
collagen fibers at the insertion presumably were the cause of
increased insertion strain and reduced biomechanical properties.12
These results indicate a role for Ihh signaling in controlling and
regulating cellular differentiation and maturation of the enthesis
fibrocartilaginous zones. In endochondral bone ossification, Ihh is
expressed by pre-hypertrophic chondrocytes and stimulates the
expression of parathyroid hormone-related peptide (PTHrP).80 To-
gether, Ihh and PTHrP form a negative feedback loop that regulates
chondrogenic differentiation, from pre-hypertrophic to hypertro-
phic chondrocytes, as well as the rate of cell proliferation.73 Wang
et al demonstrated that the development of the fibrous enthesis is
regulated by expression of PTHrP, and deletion of this gene re-
sulted in development of fibrocartilaginous tuberosities and
fibrochondrocytes at the fibrous insertion.81 It is, however, still
uncertain whether Ihh also functions to some extent together with
PTHrP in the development of the fibrocartilaginous enthesis. A
study by Amano et al found the Ihh-specific transcription factors
Gli1 and Gli2 to directly bind to and increase the activity of the
promoter for collagen type X.4 In addition, they found Ihh to
induce expression of the hypertrophic transcription factor runt-
related transcription factor 2 (Runx2) and AP.4 Furthermore, they
found the presence of a transcriptional complex on the collagen X
promotor, consisting of Gli1/2, Runx2, and Smads of the BMP-2
pathway.4 BMP signaling has previously been correlated to the
proliferative regulation of chondrocytes and found to regulate hy-
pertrophic differentiation through Smad activation.29,52
TGF-β is important for differentiation and growth during skel-
etal connective tissue development but also for inflammation and
repair.47,50 Mammals have 3 TGF-β isoforms (1-3). During devel-
opment, TGF-β3 is expressed at E13.5 in the connective tissue of
the SS tendon, with a shift of expression to TGF-β1 at E15.5
(Table I).23 No expression of either of the 2 isoforms is detected post-
natally. TGF-β protein is also found in pre-chondrogenic
mesenchymal cells, but active TGF-β signaling ceases as cells dif-
ferentiate into chondrocytes.47 TGF-β is also capable of inducing
upregulation of both tenogenic genes (Scx and tenomodulin) and chon-
drogenic genes (Sox9 and aggrecan), depending on the presence of
transcriptional regulators and activation of intracellular signaling
cascades.47 Akiyama et al showed that differentiation of pre-
hypertrophic chondrocytes to hypertrophic chondrocytes is inhibited
by Sox9 expression.3 Therefore, excessive expression of TGF-β may
have a negative influence on development of the fibrocartilaginous
zone. This implies that the microenvironment modulates TGF-β func-
tions through strict control of transcriptional regulators (Fig. 2).
Altogether, this indicates an early regulation of enthesis devel-
opment in which TGF-β directs the formation of the Scx+/Sox9+
progenitor pool.10 Tenocytes of the developing tendon then estab-
lish the formation of the attachment to the primary cartilage
through Scx/BMP-4 signaling to the eminence cells.11 Here, enthesis
cell number expands, causing lengthening of the enthesis, fol-
lowed by gradual cell differentiation postnatally, starting at the
base of the enthesis and moving toward the tendon midsubstance.
As the cells differentiate, they change collagen type expression,
creating the extracellular matrix gradient. This differentiation of
nonmineralizing fibrochondrocytes to mineralizing fibrochondrocytes
is driven by Ihh expression. Together these steps lead to the
formation of a mature enthesis with a cellular and mineralized
gradient (Fig. 3).
742 P.T. Jensen et al.
The importance of biomechanical impact on the
developing enthesis
Muscle loading of the developing enthesis is important for a func-
tional mature enthesis.77 Lack of muscle load during development
results in decreased enthesis mineralization, with disorganized cell
patterns and lack of a fully developed 4-zone transition.76,77 Studies
on paralyzed mouse shoulders demonstrated that mineralization oc-
curred at a slower rate, with increased resorption of the mineralized
fibrocartilage.76,77 The insertion of the enthesis into the humeral head
on the paralyzed shoulder was found to be much more porous and
to consist of nonmineralized cartilaginous tissue compared with the
normal shoulder.77 The mineralization rate between the paralyzed
and normal entheses was found to be unaffected, whereas the ini-
tiation of the mineralization front was delayed in the paralyzed
shoulders.76 The researchers believed that the delay in mineraliza-
tion initiation was due to muscle unloading affecting chondrocyte
hypertrophy.76 Muscle unloading also increases the population of
Ihh-responsive cells in late postnatal development, further support-
ing the role of muscle stimulation in enthesis maturation.66
In regard to enthesis healing after RC repair, immediate and pro-
longed loading seems to provide adverse effects for enthesis healing.34
Furthermore, low-force loading improves healing, whereas com-
plete removal of loading is deleterious.22,26,34 These results imply a
delicate balance between improved or impaired healing and loading
and require further data to provide firm recommendations for optimal
postoperative loading for enhanced healing.
Inflammation of the enthesis
Studies of patients with RC tears have correlated an increase in tear
size with a greater proinflammatory response in the adjacent
synovium.2,70 This has been associated with the inflammatory de-
generation of the enthesis after SS tears.2,70 As the enthesis is a site
of high muscle loading and stress, it is subject to wear and tear with
age, and therefore the inflammatory response at the synovium may
be a secondary event, following release of damage-associated mo-
lecular patterns from entheseal damage. In full-thickness RC tears,
increased numbers of inflammatory cells, such as myeloid cells, have
been demonstrated in the inflamed synovial tissue.2 Upregulation
of the proinflammatory mediators interleukin (IL)-1β, IL-6, IL-8,
tumor necrosis factor (TNF), matrix metalloproteinase (MMP)-1,
MMP-3, and MMP-13 has been demonstrated in the inflamed
synovium and SS enthesis2,28 and in the subacromial bursa of RC
tear patients.9,79 In addition, Gotoh et al observed degradation of the
SS enthesis osteochondral tissue in torn RCs, where formation of
granulation tissue with macrophages and multinucleated osteo-
clasts were found adjacent to the osteochondral tissue.28 These
multinucleated cells are able to degrade bone tissue.16 An impor-
tant factor in controlling the activity and differentiation of these
Figure 2 A schematic representation of the transforming growth factor β (TGF-β)–induced differentiation. TGF-β induces the specifica-
tion of the multipotent Scx+/Sox9+ cell line from the progenitor cells of the primary cartilage, which forms the bone eminence from which
the enthesis develops. These cells may differentiate to either tenocytes or chondrocytes by regulation of scleraxis (Scx) and SRY-box 9 (Sox9).
After chondrogenesis, Indian hedgehog (Ihh) induces hypertrophic differentiation. At this stage, the chondrogenic cells downregulate Sox9
expression as it inhibits the transition from pre-hypertrophic to hypertrophic chondrocytes. Runt-related transcription factor 2 (Runx2) is
expressed by pre-hypertrophic chondrocytes and initiates transcription of hypertrophic-related genes. Collagen type X (ColX) and alkaline
phosphatase (AP) are expressed by the hypertrophic chondrocytes at the onset of mineralization. Tenocytes express the tenogenic transcrip-
tion factor Scx. TGF-β also has the capacity to induce differentiation of mesodermal cells into both tenocytes and chondrocytes, depending
on regulation of transcriptional regulators such as TGF-β–induced homeobox 1 (Tgif1).
The supraspinatus enthesis 743
multinucleated osteoclast cells is the receptor activator of nuclear
factor-κB (RANK) and its ligand (RANKL), which activate down-
stream transcription factors nuclear factor-κB (NF-κB), activator
protein 1 (AP-1), and nuclear factor of activated T cells 1 (NFATc1),
inducing osteoclastogenesis.85 The granulation tissue was found in
almost all of the torn tendons, implying that the formation of gran-
ulation is a distinct entity in tendon degradation.28 Results from studies
indicate that cartilage and proteoglycan degradation facilitates cel-
lular invasion and formation of granulation tissue.36,43
TNF is a major cytokine in the inflammatory response and induces
expression of several other cytokines.48,56,63 IL-1β is secreted from
macrophages and binds to IL-1 receptor 1 (IL-RI) on target cells.38
IL-1β increases the production of MMPs and prostaglandin E2.17 The
chemokine IL-8 is expressed by both synovial macrophages and sy-
novial fibroblasts and serves to recruit monocytes and neutrophils
to the inflamed synovium, contributing to osteoclast expansion and
pannus formation.33,60 MMP-1, MMP-3, and MMP-13 are able to
degrade proteins such as collagen types 1, 2, and 3 and proteoglycans57
and to regulate the activity of several cytokines.57
IL-6 is an inflammatory cytokine with both proinflammatory and
anti-inflammatory functions.18 IL-6 signal transduction through its
membrane-bound receptor (IL-6R), classical signaling, is believed
to mediate anti-inflammatory activities. Signal transduction through
the soluble IL-6 receptor (sIL-6R), trans-signaling, is believed to
mediate proinflammatory activities.25 On binding to its receptor, the
IL-6/sIL-6R complex associates with the membrane-bound glyco-
protein 130 (gp130), which then relays the signal.25 IL-6 attracts
monocytes by inducing IL-8 synthesis from resident cells and induces
monocyte differentiation into macrophages.65 IL-6, TNF, and IL-1
have also been shown to stimulate RANKL expression on syno-
vial fibroblast and osteoblast cells, leading to osteoclastogenesis.32,53
The induction of RANKL expression seems to be mediated mainly
by activation of signal transducer and activator of transcription 3
(STAT3) through IL-6 trans-signaling. IL-6 is thus able to directly
stimulate RANKL expression, whereas TNF and IL-1 indirectly stim-
ulate RANKL expression by increasing IL-6.32,53
Although TNF and IL-1 depend on IL-6 for osteoclast-induced
differentiation, studies have reported direct RANKL/RANK and IL-
6–independent osteoclast differentiation by these cytokines. Bone
marrow–derived macrophages (osteoclast precursor cells) can dif-
ferentiate into osteoclasts directly after IL-1 stimulation without IL-
6. Overexpression of IL-RI enables IL-1 to induce osteoclast
differentiation without RANKL stimulation.42 Furthermore, RANKL-
stimulated bone marrow–derived macrophages upregulate IL-1RI
Figure 3 A graphical representation of the developing enthesis. Early in fetal development, the entheseal progenitor cells (green) prolif-
erate, lengthening the enthesis. These cells express collagen type 1 (first column). As the progenitor cells proliferate, the cells at the base of
the developing enthesis differentiate into unmineralizing fibrochondrocytes (light blue), stimulated by both bone morphogenic protein 4 (BMP4)
and Indian hedgehog (Ihh). These cells express both collagen types 1 and 2 (second column). During postnatal development, the fibrochondrocytes
undergo hypertrophic differentiation from the base of the enthesis, stimulated by Ihh (third column). As the fibrochondrocytes become hy-
pertrophic mineralizing fibrochondrocytes (dark blue), they express both collagen type X and alkaline phosphatase (AP), with the onset of
matrix mineralization (fourth column). (For interpretation of the references to color in this figure legend, the reader is referred to the web
version of this article.)
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expression through the transcription factors c-Fos and NFATc1 while
downregulating expression of the antagonistic receptor IL-RII. This
indicates that IL-1 can induce osteoclast differentiation, after initial
RANKL stimulation, thereby increasing bone erosion activity without
the presence of IL-6.42 Another study found the combination of TNF
and IL-6 to induce osteoclastogenesis in RANK-deficient mice.58
In this study, IL-6R was necessary for TNF/IL-6–induced
osteoclastogenesis, demonstrating that the increase in the osteo-
clast population after TNF/IL-6 stimulation was largely due to
increased cell proliferation.58 Histologic analysis showed indistin-
guishable cartilage damage between control and RANK-deficient
mice.58 In addition, the study identified osteoclasts in the inflamed
synovium of RANK-deficient mice. TNF signaling through TNF re-
ceptor 1 (TNF-R1) stimulates osteoclast differentiation by enhancing
RANKL-induced osteoclast differentiation.85 TNF also stimulates
osteoclast survival and inhibits the differentiation of osteoblast-
precursor cells into mature osteoblasts.1,27 Together, this indicates
several stimuli in the inflammatory environment for osteoclast dif-
ferentiation, leading to excessive bone erosion.
IL-6 inhibits proliferation of synovial fibroblasts and stimu-
lates expression of tissue inhibitor of MMP 1 (TIMP-1) in both
synovial cells and chondrocytes.56,71 The inhibitory effect ob-
served by IL-6 is suggested to be due to a negative feedback
mechanism on TNF-stimulated proliferation of synovial fibro-
blasts, as TNF induces IL-6 production from these cells.56
Interestingly, though, both studies reported that the IL-6/sIL-6R
complex, and thus trans-signaling, mediated the inhibitory effect and
production of TIMP-1, rather than the classical signaling pathway.56
Therefore, this may be a regulatory mechanism of the IL-6
proinflammatory response to control proliferation of synovial cells
and MMP activity during elevated IL-6 levels. However, a study by
Deon et al investigated the crosstalk between IL-6 and IL-1 in sy-
novial fibroblasts.18 They found IL-1β to inhibit expression of IL-
6–induced TIMP-1 and both IL-1β and TNF to modulate IL-6.18
Therefore, IL-6 may not inhibit the proliferation of synovial fibro-
blasts and MMP activity in the inflammatory environment. This
suggests a complex interplay between the inflammatory mediators
present, in which proinflammatory cytokines are able to regulate the
activity of anti-inflammatory cytokines, thereby inducing chronic
inflammation (Fig. 4). Altogether, these events tip the balance toward
excessive degradation of the enthesis tissue matrix.
Administering anti-inflammatory drugs, such as nonsteroidal anti-
inflammatory drugs (NSAIDs), is a common treatment for reducing
the inflammatory response after injury. However, a study by Cohen
demonstrated that use of NSAIDs after acute SS repair in rats com-
pletely inhibited SS enthesis healing.15 The control group showed
increased collagen organization over time, and fibrocartilage forma-
tion was noticed. However, the experimental group did not show any
improvement over time and demonstrated a markedly disorganized
collagen structure and no evidence of fibrocartilage formation. Os-
teoclast numbers decreased faster without NSAID treatment, and
NSAID-treated rats revealed impaired osteoblast differentiation.15 These
results indicate that NSAID treatment has adverse effects on enthesis
healing, possibly by inhibiting osteoblast differentiation, and pro-
motes further matrix degradation by excessive osteoclastic activity.15
MMP and TIMP matrix regulation
Turnover of the extracellular matrix is a dynamic balance between
synthesis and degradation. This balance is essential for proper healing,
leading to pathologic conditions when it is uncontrolled.13 MMPs
are major mediators of remodeling, able to degrade essentially every
component of the extracellular matrix.13 Activity of MMPs is regu-
lated by their natural endogenous inhibitors, TIMPs. Balanced
expression levels of MMPs and TIMPs are therefore critical in pre-
serving the integrity of the extracellular matrix.
Modulation of MMP activity in the healing response also has
potential to improve clinical outcome. By inhibiting MMPs during
healing, excessive degradation of the matrix and the severity of the
degradative inflammatory response can be reduced.57 In a study using
doxycycline to inhibit MMP activity in an acute rat SS injury model,
both preoperative and postoperative administration demonstrated an
increased development of fibrocartilage and significantly in-
creased collagen organization in early healing compared with the
control group.5 These results indicate that inhibition of MMPs during
healing can potentially improve healing.57 In addition, a study by
Gulotta et al found MMP-14, a membrane-bound MMP, to signifi-
cantly improve enthesis healing after applying MMP-14–transduced
mesenchymal stem cells (MSCs) compared with normal MSCs.31
Overexpression of MMP-14 increased fibrocartilage at the enthesis
4 weeks after unilateral detachment and repair of the rat SS tendon.31
Overexpression of MMP-14 at the enthesis also showed a signifi-
cant increase in biomechanical strength with higher ultimate load
and stress to failure and higher stiffness than in MSC-treated rats.31
SS enthesis healing
Unacceptable high retear rates after RC tendon repair are still
reported.64 Improved suture techniques have not changed the numbers
of tendon failures significantly. The major problem in the treat-
ment of RC tears is the inadequate healing of torn tendons, as the
enthesis does not regenerate its native structure. Instead, it heals in
a scar-mediated fashion, leading to an enthesis with biomechani-
cally inferior properties.14,24,37,41,44,50 The proliferation of injured enthesis
cells and expression of collagen types 1 and 3 increase signifi-
cantly after injury.24 In a rat SS tendon repair model, cell proliferation
increased to a maximum 7 days after injury and thereafter de-
creased steadily over time but remained elevated compared with the
preinjury level.24 Collagen type 1 and 3 mRNA expression reached
a maximum at day 10, followed by a decrease to nearly normal levels
56 days after injury, but in contrast to type 1, the expression of type
3 remained elevated for several days longer before decreasing. Col-
lagen type 1 accumulated slowly over time, whereas collagen type
3 followed the mRNA expression of collagen type 3.24 Normally,
the enthesis does not contain significant amounts of collagen type
3. Therefore, elevated levels may indicate a remodeling response
with immature, disorganized collagen type 3 in the early healing
response, which is then subsequently replaced.24 This was sup-
ported by Kanazawa et al, who also investigated the structure of the
healing enthesis at several time points after RC repair in rats.37 The
study revealed low organization of collagen, with significantly reduced
biomechanical properties. The collagen organization, mineraliza-
tion, and biomechanical properties improved considerably from 4
to 12 weeks, although it never obtained properties comparable to
those of the native enthesis.37 At 4 weeks, an increase in cellular
density was observed, which decreased over time to normal, com-
pared with the native enthesis. Interestingly, the study also revealed
a change in the morphology of enthesis cells from a normal chon-
droid shape to an ellipsoidal shape. Likewise, cell processes also
changed from oriented parallel to the adjacent collagen fibers to
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disoriented processes. These morphologic changes did not reverse
to the native state.37 Several studies have found the expression of
TGF-β to increase significantly after injury.24,39,46,49 Galatz et al found
the expression of TGF-β1 to be localized at the site of scar tissue
formation, whereas low TGF-β3 expression was confined to the un-
injured tissue.24 The development of the collagen “patch” may
therefore be due to increased TGF-β expression. This directs the de-
position of collagen types 1 and 3 while also inhibiting chondrogenic
differentiation, preventing the regeneration of the native enthesis.
There is mounting evidence that early intervention to restore
the tendon-bone connectivity is an important strategy for
maximizing recovery after RC tears. To prevent retear after RC
repair, a number of studies have examined the effects of various
biologic agents on tendon-to-bone healing in animal models.
These techniques have included application of exogenous growth
factors, growth factors in an engineered matrix, platelet-rich
plasma, stem cell injections, and stem cells in an engineered
matrix.62
Figure 4 A graphical representation of the synovial inflammatory response contributing to enthesis degradation. Both tumor necrosis factor
(TNF) and interleukin (IL)-1β induce production of matrix metalloproteinase (MMP) molecules from resident synovial macrophages and
induce synovial fibroblast (SF) expression of IL-6. IL-8 stimulates the recruitment of inflammatory cells, such as monocytes. TNF and IL-1
inhibit IL-6 from stimulating SF production of tissue inhibitor of MMP 1 (TIMP-1). IL-6 also associates with soluble IL-6 receptor (sIL-
6R) and then binds to glycoprotein 130 (gp130) proteins on the SF surface. gp130 then activates the transcription factor signal transducer
and activator of transcription 3 (STAT3) to induce expression of receptor activator of nuclear factor-κB ligand (RANKL). RANK/RANKL
interact with macrophages to initiate osteoclast differentiation of these cells. These events lead to degradation of the enthesis tissue. TNF
and IL-1β are furthermore able to independently induce RANKL upregulation and macrophage differentiation through their receptors, TNF-
R1 and IL-1RI.
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Several studies have investigated the potential of TGF-β3 to drive
scar-mediated healing responses toward more regenerative healing
responses.41,44,50 TGF-β3 induces chondrogenic differentiation of
MSCs from torn RC tendons and reduces scar tissue formation in
a cutaneous rat incision wound model.55,68 By using a heparin/fibrin-
based delivery system of TGF-β3, Manning et al reported
improvements in SS enthesis healing after sustained delivery of TGF-
β3 during a period of 6 weeks compared with control. Although TGF-
β3 did lead to early improvements in biomechanical properties, these
were still inferior to the uninjured enthesis.50 The treatment also did
not lead to a reduction in scar tissue formation as expected, but instead
a more disorganized scar tissue was noticed.50 This suggests that adult
fibroblast tissue has a different response to TGF-β3 than progeni-
tor cells present prenatally.50 A study by Kim et al found no
improvements in biomechanical properties or reduction in scar tissue
when delivering TGF-β3 and neutralizing antibodies for both TGF-
β1 and TGF-β2 but did find indications of fibrocartilage at the repair
site.41 The absence of improved healing may be due to the drug de-
livery method used, as antibodies were delivered to the bursal surface
and not directly to the repair interface.41
A study by Ousema et al investigated the effect of IL-1β on chon-
drogenesis of human MSCs.52 They found that IL-1 levels in diseased
joints completely inhibited chondrogenesis. Even in treating with
TGF-β3, chondrogenesis and biomechanical improvements were ef-
fectively inhibited.59 Wehling et al supported these results and found
the same effect with TNF.82 Both IL-1β and TNF suppressed chon-
drogenic differentiation through NF-κB expression, and Sitcheran
et al further found TNF to suppress chondrogenic stimulation through
NF-κB by downregulation of Sox9 expression.72 Thus, using TGF-
β3 alone might not be useful for clinical treatment.
Inhibition of TNF has also shown improved enthesis healing in
rats at the early time points after injury.30 A study by Gulotta et al
systemically inhibited TNF using the TNF inhibitor pegylated soluble
TNF-R1 and found increased fibrocartilage and a significant im-
provement in load to failure and stiffness compared with untreated
rats 4 weeks after SS repair.30 No differences in either cartilage for-
mation or biomechanical strength were seen between groups 8 weeks
after repair.30 Therefore, as most repair failures occur in the early
stages of tissue healing, administration of cytokine inhibitors may
enhance the strength of the early healing response, preventing repair
failure. Data from a recent study by Honda et al suggest that clin-
ical application of hyaluronic acid improves tendon-to-bone healing
4 and 8 weeks after RC repair.35 The study found hyaluronic acid
to accelerate chondrogenic differentiation of MSCs and thereby in-
crease the formation of fibrocartilage.35 Thus, future treatment plans
may involve application of exogenous hyaluronic acid and MSCs
to decrease the number of retears after surgery.
Collagen deposition, loss of a 4-zone structure, and absence of
significant improvements in TGF-β treatment may reflect exces-
sive TGF-β1 expression after enthesis tear. Different TGF-βs signal
through the same receptor complex. Therefore, released TGF-β1 may
compete with TGF-β3 for receptor binding, leading to a reduction
in the effectiveness of TGF-β3 treatment. However, cells in adult
tissue may react differently to TGF-β3 stimulation than fetal cells.
A possible treatment solution to improve healing could be a com-
bination of TGF-β3 together with a cytokine antagonist and possibly
TGF-β–neutralizing antibodies or MMP inhibitors.
Future discoveries may therefore present treatment with growth
factors, cytokine inhibitors, scaffolds, and stem cell treatment to
improve the development of a proper fibrocartilaginous transition
and to increase the strength of the healing enthesis.
Conclusion
In this review, we investigated existing knowledge about
assembly, maturation, and degradation of the SS enthesis.
Although recent discoveries have improved our under-
standing of the complex fibrocartilaginous enthesis, much
remains to be learned. More research into the inflamma-
tory cascades taking place in the RC tissues after surgical
repair will, it is hoped, pave the way for better clinical
treatments.
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